USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | -51 Thousand | -23 Thousand | -228 Thousand | -217 Thousand | -193 Thousand | -239 Thousand |
Net Income | 95.08 Million | -1.41 Million | -1.1 Million | -1.56 Million | -736 Thousand | -1.56 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 1.26 Million | 1.38 Million | 1.28 Million | 1.35 Million | 1.41 Million | 1.32 Million |
Other non-cash items | -96.39 Million | -1000.00 | -410 Thousand | 61 Thousand | -875 Thousand | 34 Thousand |
Investing Cash Flow | - | - | - | - | 560 Thousand | -560 Thousand |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 560 Thousand | -560 Thousand |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | 13 Thousand | -13 Thousand |
Accounts payables | 3000.00 | -3000.00 | -9000.00 | -61 Thousand | 21 Thousand | -21 Thousand |
Inventory | 10 Thousand | 4000.00 | - | - | - | - |
Other working capital | 1.25 Million | 1.38 Million | 1.29 Million | 1.41 Million | 1.39 Million | 1.34 Million |
Cash at beginning of period | 58 Thousand | 81 Thousand | 309 Thousand | 526 Thousand | 159 Thousand | 958 Thousand |
Cash at end of period | 7000.00 | 58 Thousand | 81 Thousand | 309 Thousand | 526 Thousand | 159 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -51 Thousand | -23 Thousand | -228 Thousand | -217 Thousand | 367 Thousand | -799 Thousand |
Free Cash Flow | -51 Thousand | -23 Thousand | -228 Thousand | -217 Thousand | -193 Thousand | -239 Thousand |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | 95.08 Million | 95.08 Million | -388 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 1.26 Million | -51 Thousand | - |
Other non-cash items | - | - | - | -96.39 Million | -95.08 Million | 388 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | 3000.00 | 3000.00 | - |
Inventory | - | - | - | 10 Thousand | 10 Thousand | - |
Other working capital | - | - | - | 1.25 Million | -64 Thousand | - |
Cash at beginning of period | - | - | 7000.00 | 58 Thousand | 20 Thousand | 33 Thousand |
Cash at end of period | - | - | 7000.00 | 7000.00 | 7000.00 | 20 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | -51 Thousand | -13 Thousand | -13 Thousand |
Free Cash Flow | - | - | - | -51 Thousand | -51 Thousand | -388 Thousand |
002320
CINELINE
OMAXE
9025
EMLAF
SAMHI